Fondaparinux Sodium and Pasireotide Extended-Release Injection
Determining the interaction of Fondaparinux Sodium and Pasireotide Extended-Release Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: fondaparinux
Brand name: Arixtra, Arixtra 5 mg/dose, Arixtra 75 mg/dose, Arixtra 10 mg/dose
Synonyms: Fondaparinux
Generic Name: pasireotide
Brand name: Signifor, Signifor LAR
Synonyms: Pasireotide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fondaparinux Sodium-Pasireotide Injection
- Fondaparinux Sodium-Pasireotide Subcutaneous
- Fondaparinux Sodium-Patanase
- Fondaparinux Sodium-Patiromer
- Fondaparinux Sodium-Patiromer Sorbitex Calcium
- Fondaparinux Sodium-Pavacot
- Pasireotide Extended-Release Injection-Fondaparinux Subcutaneous
- Pasireotide Extended-Release Injection-Foradil
- Pasireotide Extended-Release Injection-Foradil Aerolizer
- Pasireotide Extended-Release Injection-Forane
- Pasireotide Extended-Release Injection-Forfivo XL
- Pasireotide Extended-Release Injection-Formerly available as Dalmane